Blue Trust’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Blue Trust's AUPH Position: Q3 2026 in Review
Blue Trust sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2026, closing a stake of 690 shares — an estimated $11.7K sold.
Blue Trust first reported a position in AUPH in Q4 2022 and held it in 10 quarters. The position peaked at $72.7K in Q3 2025. 213 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Blue Trust reported no remaining Aurinia Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 690 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $11.7K.
- Blue Trust first reported a position in Aurinia Pharmaceuticals in Q4 2022 and held it in 10 quarters.
- Blue Trust's Aurinia Pharmaceuticals position peaked at $72.7K in Q3 2025.
- 213 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.